CoChat

Dietary Restriction Ameliorates Diabetic Nephropathy through Anti-Inflammatory Effects and Regulation of the Autophagy via Restoration of Sirt1 in Diabetic Wistar Fatty (fa/fa) Rats: A Model of Type 2 Diabetes

Open access
Kitada, Munehiro, Takeda, Ai, Nagai, Takako, Ito, Hiroki, Kanasaki, Keizo, Koya, Daisuke · 2011 · Experimental Diabetes Research

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Aim. Despite the beneficial effects of dietary restriction (DR) on lifespan, age-related diseases, including diabetes and cardiovascular diseases, its effects on type 2 diabetic nephropathy remain unknown. This study examined the renoprotective effects of DR in Wistar fatty (fa/fa) rats (WFRs).Methods. WFRs were treated with DR (40% restriction) for 24 weeks. Urinary albumin excretion, creatinine clearance, renal histologies, acetylated-NF-κ B (p65), Sirt1 protein expression, and p62/Sqstm 1 accumulation in the renal cortex, as well as electron microscopic observation of mitochondrial morphology and autophagosomes in proximal tubular cells were estimated.Results. DR ameliorated renal abnormalities including inflammation in WFRs. The decrease in Sirt1 levels, increase in acetylated-NF-κ B, and impaired autophagy in WFRs were improved by DR.Conclusions. DR exerted anti-inflammatory effects and improved the dysregulation of autophagy through the restoration of Sirt1 in the kidneys of WFRs, which resulted in the amelioration of renal injuries in type 2 diabetes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2011/908185

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 DR ameliorates urinary albumin excretion (a) and creatinine clearance (Ccr) (b) in Wistar fatty rats (WFRs). Treatment with DR reduced urinary albumin excretion and improved Ccr in WFRs. Data are means ± SD (n = 9 − 11, # P < 0.01 versus other groups, ## P < 0.05 versus other groups).
Figure 1 DR ameliorates urinary albumin excretion (a) and creatinine clearance (Ccr) (b) in Wistar fatty rats (WFRs). Treatment with DR reduced urinary albumin excretion and improved Ccr in WFRs. Data are means ± SD (n = 9 − 11, # P < 0.01 versus other groups, ## P < 0.05 versus other groups).CC BY · PubMed Central
Figure 2 DR ameliorates mesangial expansion and renal fibrosis in WFRs. ((a)-(A) through (D)) Representative photomicrographs of PAS-stained kidney sections from four groups of rats. Data are the results of independent experiments in each group with six rats per group. Original magnification, ×400. (b) Quantitative assessment of the mesangial matrix area in the four groups of rats. Data are means ± SD. (n = 6, # P < 0.01 versus other groups). Treatment with DR reduced glomerular and interstitial fibrosis in WFRs. ((a)-(E) through (H), (I) through (L)) Representative photomicrographs of Masson-Trichrome staining in the four groups of rats. Data are the results of independent experiments in each group with six rats per group. Original magnification, ×400 for glomerular fibrosis and ×100 for interstitial fibrosis. (c) and (d) Quantitative assessment of fibrosis in the four groups of rats. Data are means ± SD (n = 6, # P < 0.01 versus other groups).
Figure 2 DR ameliorates mesangial expansion and renal fibrosis in WFRs. ((a)-(A) through (D)) Representative photomicrographs of PAS-stained kidney sections from four groups of rats. Data are the results of independent experiments in each group with six rats per group. Original magnification, ×400. (b) Quantitative assessment of the mesangial matrix area in the four groups of rats. Data are means ± SD. (n = 6, # P < 0.01 versus other groups). Treatment with DR reduced glomerular and interstitial fibrosis in WFRs. ((a)-(E) through (H), (I) through (L)) Representative photomicrographs of Masson-Trichrome staining in the four groups of rats. Data are the results of independent experiments in each group with six rats per group. Original magnification, ×400 for glomerular fibrosis and ×100 for interstitial fibrosis. (c) and (d) Quantitative assessment of fibrosis in the four groups of rats. Data are means ± SD (n = 6, # P < 0.01 versus other groups).CC BY · PubMed Central
Figure 3 TGF-β, fibronectin, and collagen IV mRNA expression levels in the kidney. The mRNA expression levels of TGF-β (a), fibronectin (b), and collagen IV (c) were quantified using real-time PCR and expressed as fold increases from Wistar lean rats (WLRs). Data are means ± SD (n = 9 − 11, # P < 0.05 versus other groups).
Figure 3 TGF-β, fibronectin, and collagen IV mRNA expression levels in the kidney. The mRNA expression levels of TGF-β (a), fibronectin (b), and collagen IV (c) were quantified using real-time PCR and expressed as fold increases from Wistar lean rats (WLRs). Data are means ± SD (n = 9 − 11, # P < 0.05 versus other groups).CC BY · PubMed Central
Figure 4 Treatment with DR suppresses the number of ED-1-positive cells in the kidney of WFRs. ((a)-(A) through (H)) Representative photomicrographs of renal ED-1-positive cells in the four groups of rats. Data are the results of independent experiments in each group with six mice per group. Original magnification, ×400 for glomerular ED-1 staining and ×100 for tubule-interstitial ED-1 staining. (b) and (c) ED-1-positive cells in glomerular and tubulointerstitial lesions. Data are means ± SD (n = 6, # P < 0.05 versus other groups, ## P < 0.01 versus other groups).
Figure 4 Treatment with DR suppresses the number of ED-1-positive cells in the kidney of WFRs. ((a)-(A) through (H)) Representative photomicrographs of renal ED-1-positive cells in the four groups of rats. Data are the results of independent experiments in each group with six mice per group. Original magnification, ×400 for glomerular ED-1 staining and ×100 for tubule-interstitial ED-1 staining. (b) and (c) ED-1-positive cells in glomerular and tubulointerstitial lesions. Data are means ± SD (n = 6, # P < 0.05 versus other groups, ## P < 0.01 versus other groups).CC BY · PubMed Central
Figure 5 MCP-1, ICAM-1, and VCAM-1 mRNA expression levels in the kidney. The mRNA expression levels of MCP-1 (a), ICAM-1 (b), and VCAM-1 (c) were quantified using real-time PCR and expressed as fold increases from Wistar fatty rats. Data are means ± SD (n = 9 − 11, # P < 0.05 versus other groups).
Figure 5 MCP-1, ICAM-1, and VCAM-1 mRNA expression levels in the kidney. The mRNA expression levels of MCP-1 (a), ICAM-1 (b), and VCAM-1 (c) were quantified using real-time PCR and expressed as fold increases from Wistar fatty rats. Data are means ± SD (n = 9 − 11, # P < 0.05 versus other groups).CC BY · PubMed Central
Figure 6 Acetylated-NF-κB (p65) and Sirt1 expression in the kidney. (a) Representative immunoblots of Sirt1, acetylated-NF-κB (p65), and NF-κB in protein extracts from the kidneys of rats of each group. Actin was loaded as an internal control. (b) Quantitative analysis of acetylated-NF-κB (p65) protein expression. (c) Quantitative analysis of Sirt1 protein expression. Data are means ± SD (n = 6, # P < 0.01 versus other groups, ## P < 0.05 versus other groups).
Figure 6 Acetylated-NF-κB (p65) and Sirt1 expression in the kidney. (a) Representative immunoblots of Sirt1, acetylated-NF-κB (p65), and NF-κB in protein extracts from the kidneys of rats of each group. Actin was loaded as an internal control. (b) Quantitative analysis of acetylated-NF-κB (p65) protein expression. (c) Quantitative analysis of Sirt1 protein expression. Data are means ± SD (n = 6, # P < 0.01 versus other groups, ## P < 0.05 versus other groups).CC BY · PubMed Central
Figure 7 p62/Sqptm1 accumulation and electron microscopy in the kidney. (a) Representative immunoblots of p62/sequestosome 1 (Sqptm1) in protein extracts from the kidneys from rats of each group. Actin was loaded as an internal control. Data are means ± SD (n = 6, # P < 0.01 versus other groups). (b) Quantitative analysis of p62/Sqptm1expression. Data are means ± SD (n = 6, # P < 0.05 versus other groups). (c) Representative micrographs of proximal tubular cells from the, four groups of rats. Scale bar = 1 μm (n = 3).
Figure 7 p62/Sqptm1 accumulation and electron microscopy in the kidney. (a) Representative immunoblots of p62/sequestosome 1 (Sqptm1) in protein extracts from the kidneys from rats of each group. Actin was loaded as an internal control. Data are means ± SD (n = 6, # P < 0.01 versus other groups). (b) Quantitative analysis of p62/Sqptm1expression. Data are means ± SD (n = 6, # P < 0.05 versus other groups). (c) Representative micrographs of proximal tubular cells from the, four groups of rats. Scale bar = 1 μm (n = 3).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Cited by

Metadata

Authors
Kitada, M., Takeda, A., Nagai, T., Ito, H., Kanasaki, K., & Koya, D.
Affiliations
Kanazawa Medical University (JP)
Corresponding author
Koya, Daisuke
Venue
Experimental Diabetes Research
Publisher
Wiley
Published
2011
Volume
2011
Pages
1-11
ISSN
  • 1687-5214 (ISSN-L)
  • 1687-5303
OpenAlex
W2006254543
Cited by
213
References
29
Citations by year
2026: 4 · 2025: 8 · 2024: 6 · 2023: 13 · 2022: 19 · 2021: 25 · 2020: 17 · 2019: 23 · 2018: 14 · 2017: 13 · 2016: 18 · 2015: 12 · 2014: 12 · 2013: 21 · 2012: 6
FWCI
10.15
Type
journal article
Language
en
Open access
Locations
  • Experimental Diabetes Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • Ministry of Health, Labour and Welfare (S2011-2)
  • Uehara Memorial Foundation (S2011-2)
  • Kanazawa Medical University (S2011-2)
Topics
  • Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
  • Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords
dietary restriction, diabetic nephropathy, type 2 diabetes, Wistar fatty rats, SIRT1, autophagy, NF-κB, renal inflammation, p62, mitochondrial morphology, proximal tubular epithelial cells, albuminuria, renal protection
MeSH terms
Albuminuria, Animals, Autophagy, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Diet, Reducing, Fibrosis, Inflammation, Kidney, Macrophages, Male, Rats, Wistar, Rats, Sirtuin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.